No Data
No Data
Catalyst Watch: Spotlight on Tesla, Alphabet Earnings, AACR Drug Data, and Global PMI Reports
Express News | U.S. Food and Drug Administration Updates Camzyos® (Mavacamten) Label to Reduce Echocardiography Monitoring Requirements and Contraindications
U.S. Food and Drug Administration Updates CAMZYOS (Mavacamten) Label to Reduce Echocardiography Monitoring Requirements and Contraindications
BofA Securities Maintains Bristol-Myers Squibb(BMY.US) With Hold Rating, Cuts Target Price to $58
Express News | Bristol-Myers Squibb Co : BofA Global Research Cuts Price Objective to $58 From $63
Is Bristol-Myers Squibb Company (BMY) The Dirt Cheap Stock To Invest In Now?